Methods
Published on 04 Jul 2025
HRS-4642 combined with nimotuzumab in the treatment of recurrent or metastatic pancreatic ductal adenocarcinoma: study protocol of a single-arm, prospective phase Ib/II trial
in Pharmacology of Anti-Cancer Drugs
- 4,039 views








